Hhlr Advisors, Ltd. Mereo Biopharma Group PLC Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.33 - $1.69 $982,119 - $5.03 Million	-2,976,121 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.95 - $3.6 $2.69 Million - $4.96 Million	1,377,936 Added 86.22%	2,976,121 $10.7 Million
Q3 2020 Nov 16, 2020	BUY	$2.55 - $3.29 $3.76 Million - $4.85 Million	1,473,215 Added 1178.85%	1,598,185 $4.19 Million
Q2 2020 Aug 14, 2020	BUY	$1.0 - $3.4 $124,970 - $424,898	124,970 New	124,970 $382,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $419M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.